Meet us at the 11th PBP World Meeting in Granada, Spain.
|
Meet us at the 11th PBP World Meeting in Granada, Spain.
|
Partner LGI prepared a video animation to provide a quick overview of the N2B-patch project.
|
N2B-patch consortium with LEGO SeriousPlay at Month 12 Meeting in January 2018 at LGI HQ in Paris. |
As part of the N2B-patch project, partner LGI ran an Exploitation workshop on 15 January 2018 during the project progress meeting hosted at the LGI HQ. The goal of the workshop was to enhance discussions on potential impacts and exploitation routes in the course of the project and beyond the development of the drug delivery technology for the chronic treatment of multiple sclerosis (MS). During the workshop, the LEGO SeriousPlay method was applied, directed by two LGI`s LEGO SeriousPlay facilitators – Chloe Chavardes and Eva Boo. They put a spin on regular workshops and provided a hands-on way of thinking about the project and easier understanding of the possibilities that the N2B-patch solution brings.
On the second and third day of the project meeting, the partners met up to present the progress made so far and plan for the work that remains to be done.
|
The N2B-patch consortium at Month-6 Meeting in July 2017 at LENS in Florence. |
On 19th and 20th July 2017 the N2B-patch consortium met for the Month-6 meeting.
Project partner LENS hosted the meeting at its facilities in Florence, Italy.
|
Meet us at the 7th Joint ECTRIMS – ACTRIMS International Conference in Paris, France. ECTRIMS – ACTRIMS is said to be the largest multiple sclerosis meeting in the world attracting multiple sclerosis experts from all over the world. Our N2B-patch team will definitely be represented with the colleagues from the European Multiple Sclerosis Platform. Will you be there, too?
Link official ECTRIMS – ACTRIMS Homepage
|
N2B-patch consortium. Kick-off meeting in January 2017 at Fraunhofer IGB in Stuttgart. |
Over the next four years, in a research project co-funded by the EU, the N2B-patch consortium will develop a new technology for a better treatment of multiple sclerosis. The idea of the innovative “Nose2Brain” approach is to transport a special active substance directly through the nose into the central nervous system. Please have a look at the press release we published for project start:
|
Share N2B-patch |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 721098
Copyright N2B-patch (Fraunhofer IGB) 2024 >©
Designed with by pixagentur